Charles Dunn
InvestorPrincipal at SV Health Investors
London
Writes $100K – $5M checks · typically $1.5M
About
Charles Dunn joined SV Health Investors in 2018 as a Principal on the biotech team, where he helps form and fund companies developing new medicines across early creation to later-stage public and private opportunities. Before SV he qualified as an ACA after three years at Deloitte serving Life Sciences clients, and has an academic background in human genetics and molecular biology from UCL.
Contact· self-published, not guessed
Invests in
Biotech
Experience
- SV Health InvestorsPrincipalcurrent2023 — present
- SV Health InvestorsVice President2022 — 2023
- SV Health InvestorsSenior Investment Associate2021 — 2022
- SV Health InvestorsInvestment Associate2019 — 2021London, United Kingdom
- SV Health InvestorsInvestment Analyst2018 — 2019London, United Kingdom
- Draig TherapeuticsMember Board of Directors & Founding Investorcurrent2024 — present
- Imbria PharmaceuticalsMember Board of Directorscurrent2023 — present
- Imbria PharmaceuticalsBoard Observer2020 — 2023
- Mestag TherapeuticsMember Board of Directorscurrent2023 — present
- Mestag TherapeuticsBoard Observer & Founding Team2020 — 2023
- PulmocideBoard Observercurrent2020 — present
- Autifony TherapeuticsBoard Observercurrent2019 — present
- Enara BioBoard Observer2020 — 2024
- ZarodexBoard Observer2019 — 2021
- Deloitte UKAssistant Manager2016 — 2017Cambridge, United Kingdom
- Deloitte UKSenior Associate (Entrepreneurial Business)2015 — 2016
- Deloitte UKAssociate (Entrepreneurial Business)2014 — 2015
Deals · 1
Draig TherapeuticsLed round
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Autifony TherapeuticsEnaraBioImbria PharmaceuticalsMestag TherapeuticsPulmocide
Per the firm's website.
Colleagues at SV Health Investors
A.J. Rossi
Partner at SV Health Investors
Aaron Sandoski
MCF Partner at SV Health Investors
Alan Foster
Managing Director at TeleSoft.AI
Alex Badamchi-Zadeh
Vice President at SV Health Investors
Amer Ramzan
Managing Partner at Promentum Equity Partners
Andrew Cappetta
Senior Associate at SV Health Investors
Brent Faduski
CFO, CCO and Partner at SV Health Investors
Christian Jung
Partner at SV Health Investors
Network6
Alex Badamchi-Zadeh
Vice President at SV Health Investors
Christian Jung
Partner at SV Health Investors
Darren Black
Partner at SV Health Investors
Dirk Landgraf
Principal at SV Health Investors
Emily Gaudiano
Associate at SV Health Investors
Eugene Hill
Chairman at SV Health Investors
Investors connected to Charles in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Charles Dunn?
- Charles Dunn joined SV Health Investors in 2018 as a Principal on the biotech team, where he helps form and fund companies developing new medicines across early creation to later-stage public and private opportunities. Before SV he qualified as an ACA after three years at Deloitte serving Life Sciences clients, and has an academic background in human genetics and molecular biology from UCL.
- Where does Charles Dunn work?
- Charles Dunn is Principal at SV Health Investors.
- What does Charles Dunn invest in?
- Charles Dunn invests in Biotech.
- What check size does Charles Dunn write?
- Charles Dunn typically writes checks of $100K – $5M.
- What boards does Charles Dunn sit on?
- Charles Dunn holds tracked board seats at Autifony Therapeutics, EnaraBio, Imbria Pharmaceuticals, Mestag Therapeutics, Pulmocide.
- What companies has Charles Dunn invested in?
- Investments tracked here include Draig Therapeutics.
- Where did Charles Dunn go to school?
- Charles Dunn studied at UCL (MSci, Human/Medical Genetics); ICAEW (ACA); Hills Road Sixth Form College.
- Does Charles Dunn lead rounds?
- Yes — Charles Dunn has led 1 tracked investment.
Same school
Also attended UCL398
Demis HassabisCo-founder & CEO of Google DeepMindAndré DuboisInvestor at Index VenturesFrédérique DameInvestor at GV (Google Ventures)Jonas VetterleInvestor at Moonfire VenturesMarie FerriInvestor at DaphniElena PantaziPartner & Head of Platform at Northzone
+ 392 more
Also attended ICAEW134
Abdul GueforManaging Director at Intel CapitalJames BraithwaiteFinancial Controller at NorthzoneJackson HeddyCFO at NorthzoneSteph OrdeChief Financial Officer at Episode1Sian CathrallPartner (joining next fund) at 4Di CapitalStephen ChandlerManaging Partner at Notion Capital
+ 128 more
Also attended Hills Road Sixth Form College4
Shared employers
Also worked at SV Health Investors26
Victoria TaylorInvestor at MedicxiAmy SlizofskiInvestor at TRANSFORMATION CAPITALAlexander Sinclair-Wilson执行董事 at Qiming Venture PartnersPaul LaVioletteManaging Partner at SV Health InvestorsGreg MaddenManaging Partner at SV Health InvestorsEugene HillChairman at SV Health Investors
+ 20 more
